136 related articles for article (PubMed ID: 5423548)
1. [Relation between estrogen content and the risk of thromboembolism in peroral contraception].
Ugeskr Laeger; 1970 Apr; 132(18):846. PubMed ID: 5423548
[No Abstract] [Full Text] [Related]
2. [Estrogen content of oral contraceptives and thromboembolitic processes].
Rübsaam CJ
Ned Tijdschr Geneeskd; 1970 Jun; 114(26):1101-3. PubMed ID: 5448293
[No Abstract] [Full Text] [Related]
3. [Estrogen therapy for the climateric and thromboembolic risk].
Campagnoli C; Prelato L; Rossetti MG
Minerva Ginecol; 1980 May; 32(5):429-35. PubMed ID: 7393492
[TBL] [Abstract][Full Text] [Related]
4. [Letter: Thrombosis hazards due to estrogen dosage].
Lauritzen C
Med Welt; 1974 May; 25(20):919-20. PubMed ID: 4845129
[No Abstract] [Full Text] [Related]
5. [Postmenopausal estrogen therapy and thrombosis].
Bergsjo P
Tidsskr Nor Laegeforen; 1972 Dec; 92(34):2354. PubMed ID: 4650315
[No Abstract] [Full Text] [Related]
6. [Peroral contraceptives and thromboembolism].
Asperger Z
Lijec Vjesn; 1969 Jul; 91(7):779-82. PubMed ID: 4910828
[No Abstract] [Full Text] [Related]
7. A report from the Australian drug evaluation committee: oral contraceptives and thromboembolic disease.
Med J Aust; 1970 Jun; 1(25):1267-9. PubMed ID: 5459269
[TBL] [Abstract][Full Text] [Related]
8. [The pill and thromboembolism. 2. Pathogenesis and additional risk factors. Review of the literature].
Herzog C; Mall-Haefeli M
Ther Ggw; 1979 Nov; 118(11):1722-44. PubMed ID: 395715
[No Abstract] [Full Text] [Related]
9. Serious adverse effects of oral contraceptives and estrogens.
Med Lett Drugs Ther; 1976 Feb; 18(5):21-2. PubMed ID: 1256357
[No Abstract] [Full Text] [Related]
10. Oral contraception and thromboembolism: the role of progestogens.
N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolism and oral contraceptives.
Br Med J; 1974 Feb; 1(5901):213. PubMed ID: 4818158
[No Abstract] [Full Text] [Related]
12. [Oral contraception and liver function].
Bergsjo P
Tidsskr Nor Laegeforen; 1973 Mar; 93(9):583-8. PubMed ID: 4759808
[No Abstract] [Full Text] [Related]
13. Changing oral contraceptives.
Br Med J; 1969 Dec; 4(5686):789-91. PubMed ID: 5359946
[No Abstract] [Full Text] [Related]
14. Estrogens and thromboembolic diseases. Present conception of a controversial issue.
Zador G
Acta Obstet Gynecol Scand Suppl; 1976; 54():13-28. PubMed ID: 788441
[No Abstract] [Full Text] [Related]
15. Oestrogens in the pill.
Lancet; 1970 May; 1(7653):929-30. PubMed ID: 4191556
[No Abstract] [Full Text] [Related]
16. Contraception.
Swyer GI
Trans Med Soc Lond; 1972; 88():191-7. PubMed ID: 4353229
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin 3 and the estrogen content of combined estro-progestagen contraceptives.
Conard J; Samama M; Salomon Y
Lancet; 1972 Nov; 2(7787):1148-9. PubMed ID: 4117229
[No Abstract] [Full Text] [Related]
18. Letter: Side effects of oral contraceptives.
Med J Aust; 1975 Mar; 1(10):317-9. PubMed ID: 1128348
[No Abstract] [Full Text] [Related]
19. The effects of oral estrogen-progestin compounds on blood coagulation factors.
Hodges RM
Int J Fertil; 1968; 13(4):349-53. PubMed ID: 5700392
[TBL] [Abstract][Full Text] [Related]
20. [Pills and thrombosis (platelets, estrogens and magnesium)].
Durlach J
Rev Fr Endocrinol Clin; 1970; 11(1):45-54. PubMed ID: 5433250
[No Abstract] [Full Text] [Related]
[Next] [New Search]
